Calico, Denali’s ALS drugs miss primary objectives in basket study

A basket study for experimental ALS treatments recorded a pair of additional failures on Monday from two prominent companies.

New data from Google’s longevity play …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Biotech in Israel: Holding on to business as usual amid uncertain times

In the middle of our Zoom interview, Mati Gill, Tel Aviv-based CEO of venture studio AION Labs, excused himself calmly to find shelter when a

October 14, 2023

PentixaPharm Receives BfArM-Clearance for its Therapeutic to conduct a Clinical Trial in Lymphoma – Biotech Investments

EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Miscellaneous Eckert & Ziegler: PentixaPharm Receives BfArM-Clearance for its Therapeutic to conduct a Clinical

June 9, 2023

Risk Adjusted Net Present Value: What is the current valuation of PDS Biotechnology’s PDS-0101

The revenue for PDS-0101 is expected to reach an annual total of $170 mn by 2038 globally based off GlobalData’s Expiry Model. The drug’s revenue

September 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.